Evidation | Real-World Data Solutions

MULTIMODAL REAL-WORLD DATA COHORTS

Real-world data to understand behavior, outcomes, and what happens next

Through direct connections with millions of individuals, Evidation builds longitudinal, multimodal cohorts that support discovery, evidence generation, and commercial decisions by revealing treatment behavior, disease progression, and real-world outcomes over time.

Most real-world data miss how health actually unfolds over time.

Trials fail and therapies go underutilized when decisions rely on episodic data that miss behavior, experience, and change between clinical encounters. Evidation captures longitudinal, multimodal data directly from individuals to reveal treatment behavior, disease progression, and real-world outcomes over time.

Built from the Evidation Community, population cohorts enable continuous data collection, evidence generation, and engagement.

Access deeply characterized populations through one-time engagements or ongoing subscriptions, enabling longitudinal data collection, repeated measurement, and real-time engagement over time.

Identify a population

Access 5 million engaged individuals across 100+ conditions, or define a cohort aligned to your scientific or commercial objective.

Collect multi-modal data

Capture longitudinal, multimodal data directly from individuals — including clinical records, ePROs, and digital signals.

Select modular offerings

Combine data and activation offerings to support research, evidence generation, and commercialization.

Data Offerings

  1. Real-World Data: Rich multimodal datasets providing historical context
  2. Patient Insights: Understand needs, preferences, and decision drivers
  3. Prospective Studies: Sponsor driven observational research

Activation Offerings

  1. Recruitment: Find and enroll the right trial participants
  2. Activation: Drive awareness, engagement, and real-world action

Access data from existing cohorts, or build your own.

Choose from predefined groups of individuals using real-world health labels, or define a custom cohort aligned to your scientific and commercial objectives.

Featured cohorts

Additional cohorts

The Evidation Community: an ongoing connection to 5M people

Varies by population, protocol, and length of program; many of our recent programs have seen 90%+ engagement

Scaled

Characterized

Engaged

Impact for customers

Life Sciences

Consumer Health

Government

Non-Profit

Who we work with

Evidation partners include top biopharma companies, as well as consumer health companies, technology companies, non-profit organizations, and government agencies.

Our commitment to privacy, security, and compliance

%201.webp)

See how we drive success for our customers:

Exploring potential to reduce stroke risk with earlier detection of Afib

Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.

30K+ participants aged 65+ READ

Improving blood pressure in overweight individuals through a digital self-management program

Omada ran a pilot study managed by Evidation to demonstrate the value of a digital hypertension self-management program by quantifying its impact on blood pressure control. As a result of this study, Omada was able to publish evidence that their app improves blood pressure and medication adherence.

151 individuals with hypertension recruited from the Evidation Community READ

FluSmart participants receive alerts and nudges to seek care

In partnership with BARDA, Evidation developed and deployed a flu monitoring program, FluSmart, within the Evidation Community to collect rich, longitudinal data and activate high-risk participants into research and care.

200K+ individuals participated in FluSmart 90%+ engagement rate READ

Helping cardiovascular patients better understand and act on their heart health

The American College of Cardiology (ACC) launched the Heart Health patient engagement program on the Evidation platform to allow patients to track their everyday health and proactively manage their care beyond traditional clinical settings.

33K participants joined the program 87% of individuals who shared their personalized insights report with their care team found it helpful or extremely helpful READ

Identifying and addressing gaps in the patient experience

Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.

92% weekly survey completion 85% daily survey completion READ

Increasing treatment rates with co-created patient engagement

Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.

10K
individuals recruited from the Evidation Community Up to 2x
increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging READ

Creating the first large-scale, nationally representative digital health dataset

Evidation partnered with USC and the RAND Corporation on American Life in Real-time (ALiR), a first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data collected from smartphones and wearables to advance equitable precision health.

Digital engagement program launched to more than 1K participants READ

Developing an early warning algorithm for individuals at high risk for COVID-19

Evidation conducted a study to demonstrate that person-generated health data, including data from smartphones and wearable devices, has the potential to enable applications ranging from individual-level early warnings or population-level hotspot detection for COVID-19.

800+ individuals recruited from the Evidation Community

80% compliance with study activities READ

Measuring cognitive impairment with direct-from-patient real-world data

Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.

16TB of multimodal data collected over 12 weeks 1K+ features extracted from participant behaviorgrams READ

Better Understanding of the Metamorphosis of Pregnancy (BUMP)

Evidation partnered with 4YouandMe to provide a platform to manage data collection, processing, and storage for the BUMP longitudinal feasibility study aimed to gain a deeper understanding of the pre-pregnancy and pregnancy symptom experience using digital tools.

1K participants targeted for enrollment onto the platform READ

Developing more successful digital health programs with patient perspectives

Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).

114 insulin-dependent adults with T2D recruited from the Evidation community Recruitment completed in 3 weeks READ